interaction records 54 assistance programs 55 0 personal data stored

Copay help by condition · Infection · read 2026-11-08

Hepatitis C (HepC): which charitable copay funds are open

1 fund for Hepatitis C says it is open right now, of the 4 we hold (read 2026-11-08).

Open: Hepatitis C from Good Days. Eligibility is each fund's own rule.

If you have Medicare Part D: CMS prints the annual out-of-pocket threshold as $2,400 in 2027 ($2,100 in 2026) (Table V-2 of its CY 2027 announcement). It is a benefit parameter and applies to covered drugs under plan rules. What changes on January 1.

Funds by status: 1 open, 3 closed or at capacity1 open3 closed

Swipe to read across

Funds we hold for Hepatitis C, by the status each page gave on the day we read it.
What this is not. A record of what fund pages and FDA labels say, not advice and not a check of whether you qualify. US funds only. This page covers charitable funds from the organizations we read, the costs around a condition those funds pay for, and the drugs whose FDA label names the condition. A label naming a condition is not a statement that the drug is approved, effective or covered for you.

A copy for a patient, a clinic or a pharmacist, with each source and the date we read it.

Every fund we hold for Hepatitis C

  • OpenHepatitis C

    Good Days ·

    Award level: not statedInsurance supported: not stated

    The page marks the fund as open for new enrollments (the fund's list item on the page carries the class open). Source page

  • Closed or at capacityHepatitis C

    HealthWell Foundation ·

    Award level: not statedInsurance supported: not stated

    The page lists the fund as Closed. Source page

  • Closed or at capacityHepatitis C (HepC)

    TotalAssist (Patient Advocate Foundation copay funds) ·

    Award level: $6,000Insurance supported: Any health insurance

    The page lists the fund as Closed. Source page

  • Closed or at capacityHepatitis C (HepC) health equity

    TotalAssist (Patient Advocate Foundation copay funds) ·

    Award level: $6,000Insurance supported: Any health insurance

    The page lists the fund as Closed. Source page

Drugs whose FDA label names Hepatitis C

3 drugs. Each row quotes the sentence of the drug's FDA label (Indications and Usage, openFDA) that names the condition. A label naming a condition is not a statement that the drug is approved, effective or covered for you. Dashes in quotes are shown as hyphens. Of these, 2 have a program (in our assistance finder or on the program's own page) and 0 have a Medicare negotiated price in the CMS file; an empty cell says we found nothing in our data, not that nothing exists.

DrugWhat the FDA label saysManufacturer programMedicare negotiated price
Mavyret
Glecaprevir/Pibrentasvir
Every route for this drug
MAVYRET is indicated for the treatment of adult and pediatric patients 3 years and older with acute or chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5 or 6 infection without cirrhosis or with compensated cirrhosis (Child-Pugh A).
Label on openFDA, read 2026-11-10
myAbbVie Assistnot in the CMS negotiated-price file
Epclusa
Sofosbuvir/Velpatasvir
Every route for this drug
EPCLUSA is indicated for the treatment of adults and pediatric patients 3 years of age and older with chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5, or 6 infection [see Dosage and Administration (2.
Label on openFDA, read 2026-11-10
Gilead Advancing Accessnot in the CMS negotiated-price file
Promacta
Eltrombopag Olamine
... for the treatment of thrombocytopenia in patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy.
Label on openFDA, read 2026-11-10
not in our assistance findernot in the CMS negotiated-price file

No broader or more specific condition page for this one.

Group: Infection. All conditions: the condition index. Fund board for every condition: charitable copay fund status.

What changed

First read on 2026-11-08. We keep each read with its date, so a fund reopening or closing will show here as a change. Until we have a second read there is nothing to compare, and we do not guess. The read date of every source is on the changes page.

This page as data

The same facts as JSON, each fund with its source URL and read date: hepatitis-c.json. Edition 2026-11, root 006ab9a329709cbe. See the licence page.

Questions

Is there an open charitable copay fund for Hepatitis C?

As read on 2026-11-08, 1 of the 4 funds we hold for Hepatitis C say they are open: Hepatitis C from Good Days. Funds open and close, so check the source page before you apply.

Which organizations run funds for Hepatitis C?

Good Days, HealthWell Foundation and TotalAssist (Patient Advocate Foundation copay funds). Each fund row on this page links to the organization's own page.

Does an open fund mean I qualify?

No. A status says whether a fund is taking applications. Eligibility, award level and which insurance it supports are each fund's own rules; where the page states them they are shown on the fund.

How current is this page?

Statuses are what each fund's own page said on the date we read it (2026-11-08). We do not promise a fund is still in that state today.